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Experimental "allergic" encephalomyelitis (EAE) was placed firmly on im- 
munologic grounds by the sensitized lymph cell transfer studies  of  Paterson 
(2) and of Stone (3).  Since sensitized cells may produce circulating antibodies 
after transfer  (2,  4),  as well as participate in hypersensitivity reactions,  the 
pathogenesis of EAE remains unsettled. Previous studies of antibody forma- 
tion in EAE have sought to show a relationship between the level of circulating 
antibody and the incidence of disease. In general, consistent correlations have 
not been found (5-7).  However, interpretation of the data presented by such 
studies is complicated by the fact that multipotential antigens such as whole 
brain and spinal cord have been used to induce the disease and crude extracts 
of these same tissues have been employed in the in vitro detection and measure- 
ment of the antibody. The lack of a positive correlation between the incidence 
of EAE and antibody titers under such circumstances, therefore, might have 
been due to the presence of a variety of non-encephalitogenic antibodies. Efforts 
to identify the agent responsible for EAE have led recently to the isolation of 
a number of water-soluble protein fractions of nervous tissue with a high degree 
of encephalitogenic activity in guinea pigs  (8).  Although these fractions are 
not homogeneous as yet, they are of greater chemical, and presumably greater 
immunologic, purity than the whole tissue preparations previously used and, 
accordingly, less  likely to induce as wide a  variety of concomitant, non-en- 
cephalitogenic antibody. Preliminary studies have shown that of the various 
techniques explored, the ammonium sulfate precipitation method of Farr  (9) 
was most suitable for the quantitative measurement of antibody to the water- 
soluble fraction of nervous tissue employed in these studies. 
In the present study, therefore, the ammonium sulfate precipitation method 
was adapted to measure the antibody induced in rabbits by the injection of a 
* Supported by a grant from the Health Research and Services  Foundation. 
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water-soluble,  encephalitogenic fraction of rabbit cord. Since many of these 
rabbits developed EAE,  the relationships between certain immunologic and 
clinical aspects of the disease are examined and reported. 
Materials and Methods 
Preparation  of the Water-Soluble Fraction of Rabbit Cord.--A water-soluble fraction of rabbit 
spinal cord (WSF) was prepared by a modification of "Method IlI" described by Roboz and 
Henderson (10). 
The spinal cords from freshly killed, adult, albino rabbits were stripped of their meninges, 
homogenized in distilled water, and lyophilized. Approximately 30 gm of the dry cord was ex- 
tracted twice with 300 ml of acetone and once with 300 ml of ether for 24 hours at -- 7°C with 
constant stirring. The residue from the ether extraction was lyophilized for 10 minutes to 
remove the excess ether and then extracted with 300 mi of 0.5 M sodium acetate for 24 hours 
at 4°C with constant stirring. This extract was discarded and 300  ml of 0.1 M sodium citrate 
added to the residue. This mixture was adjusted to pH 4.3 and stirred constantly for 48 hours 
at 4°C. After centrifugation the supernate still retained some material in colloidal suspension 
which precipitated out upon dialysis against distilled water for 6 to 12 hours and could then 
be removed by centrifugation. Dialysis of the supernate was continued for a total of 72 hours 
and the volume of the extract reduced to 50 ml by evaporation at 4°C. Lyophilization yielded 
approximately 150 mg of a white powder. 
Radioiodination  of the Rabbit  Cord WSF.--Two mg of the WSF was dissolved in 0.5 ml of dis- 
tilled water and labeled with 5 mc of I TM according to the method of  Talmage  et  a/.  (11). 
Since 10 to 25 mg of protein are usually iodinated by this technique, the concentration of the 
carrier KI was changed from 0.01 ~s to 0.001 ~  to prevent excessive iodination and subsequent 
denaturation of the protein. The solution of I131-1abeled water-soluble fraction (I*WSF) was 
first passed through an amberlite resin column  1 and then dialyzed against a continuous flow of 
24 liters of 9:1 normal saline borate buffer and stored at 4°C. I*WSF with low specific activity 
was prepared by labeling 2 mg of antigen with 25 #c of I TM by the same technique. This ma- 
terial was dialyzed in distilled water, lyophilized, and used to determine the effect of iodination 
on the electrophoretic pattern and on the encephalitogeuic activity of the antigen. 
Characterization  of the Rabbi~ Cord WSF.--Paper  2 electrophoresis of the unlabeled WSF 
was carried out in veronai buffer, pH 8.6 at 2.5 milliamps for 17 hours. The strips were dried, 
stained with brom-phenol blue, and analyzed in the analytrol.  8 The WSF labeled with 25 #c 
of I TM was studied in a similar manner and, in addition, the stained strips were then cut trans- 
versely into 0.5 cm segments and each segment counted individually in a well-type scintillation 
counter.  4 
The solubility of the water-soluble fraction in 10 per cent trichloroacetic acid (TCA) was 
tested by the addition of 1.0 ml of 20 per cent TCA to a  mixture of 0.5 ml portions of  the 
I*WSF and 1 • 10 normal rabbit serum borate buffer. The whole was incubated for 30 minutes 
at 4°C,  centrifuged, decanted,  and radiocounted.  The radioactive counts in the precipitate 
were expressed as a per cent of the total counts added. 
A nitrogen determination was performed on the antigen by the microanai~ical colorimetric 
(Nessler) method described by Lanui et al. (12). 
1 Rezikit, E. R. Squibb & Sons, Cleveland, Ohio. 
Filter paper strips, Beckman No. 320046. 
a Spinco, Model RB  analytrol. 
Radioactive  counting was  accomplished  in  a  weU-type,  gamma  scintillation counter 
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Immunization  of Rabbits with the Rabbit Cord WSF.--Adult male,  albino rabbits which 
weighed between 2 and 3 kilos (9 to 14 weeks old) were obtained from a  single commercial 
breeder.  Spontaneous paresis or paralysis has not been observed in any of several hundred 
rabbits received from the same source.  The animals were caged in pairs and fed Rockland 
Farms ration,  s They were observed for at least 10 days prior to injection. 
The water-soluble fraction was administered in Freund's complete adjuvant. The complete 
adjuvant was prepared by the addition of 6.4 nag of Mycobacterium butyricum (MB), ground 
to a fine powder with a mortar and pestle, to each milliliter of Freund's incomplete adjuvant.  6 
Equal volumes of the complete adjuvant and distilled water containing varied amounts of 
the WSF were emulsified in a  Servall omni-mix at high speed for several 1 minute periods. 
Forty-nine rabbits received approximately 0.1  mi of this antigen adjuvant emulsion intra- 
dermally into each of the four foot-pads. Twelve rabbits received a similar amount of the com- 
plete adjuvant only and three rabbits each received 1.0 mg of the I*WSF with low specific 
activity. All animals received a total of 1.6 mg of MB. 
Blood was obtained from an ear vein prior to injection, the 7th day after injection and every 
3 to 4 days thereafter for the 1st month, and every 5 to 7 days for the 2nd month. The blood 
was allowed to clot at room temperature and after the clot had retracted the serum was re- 
moved and stored at --20°C. 
During the postinjection period,  the strength and coordination of each rabbit were  de- 
termined from the manner in which the animal moved about his cage or the floor of the animal 
room. The day that limb weakness first became apparent was designated as the day of onset 
of the disease. The extent of the clinical neurological involvement was graded solely on the 
basis of the degree of limb weakness; i.e, complete paralysis of two or more limbs within 3 
days of onset, ++++;  complete paralysis of two or more limbs in more than 3 days, +++; 
moderate paralysis of two or more limbs, ++;  and mild weakness of one or more limbs, +. 
Once either paresis or paralysis had become well established the animal was sacrificed. This 
was usually accomplished within 6 days of the onset of the disease. The surviving rabbits were 
killed 60 days after injection. All animals were exsanguinated by cardiac puncture and the 
brain and spinal cord of the sick animals were removed and fixed in 10 per cent formalin. After 
fixation, 0.5 cm blocks of tissue from both cerebral hemispheres, midbrain, pons (including the 
cerebellum), medulla, upper and midcervieal cord, upper, mid, and lower thoracic cord, and 
mid and lower lumbar cord were embedded in paraffin. Sections were stained with hematoxylin 
and eosin and for myelin by the method of Well. The severity and distribution of the micro- 
scopic lesions were made the basis of a  rough and entirely subjective method of grading the 
histologic changes. A designation of ++++  indicated the greatest and +, the least degree 
of involvement that was observed. 
Measurement of Anti-WSF by 40 Per Cent Saturated Ammonium Sulfate Precipitation.-- 
Approximately 0.1 ml of the I*WSF was diluted in 100 ml of 1:100 pooled normal rabbit serum 
borate buffer to provide about 50,000 counts/0.5 ml on the day after iodination. When the 
I*WSF was diluted for testing at longer time intervals after iodination, the same concentra- 
tion of antigen was maintained by countwise adjustment with the use of an I l~t decay chart. 
The sera to be tested were diluted 1:10 with borate buffer while subsequent dilutions were 
made with 1 : 10 pooled normal rabbit serum borate buffer.  An 0.5 ml aliquot each of the di- 
luted serum and the I*WSF were mixed in 13 X  100 mm pyrex test tubes and incubated for 2 
hours at 4°C. One mi of 80 per cent saturated ammonium sulfate (SAS) was added to each tube 
so that a final SAS concentration of 40 per cent was achieved. Since immediate and complete 
mixing was critical, the 80 per cent SAS was added as rapidly as possible with a Brewer auto- 
matic pipette to a rack of forty-eight tubes and the rack immediately shaken vigorously for 3 
s A. E. Staiey's Manufacturing Company, Decatur, Illinois. 
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minutes. The tubes were kept at 4°(2 for 30 minutes and then centrifuged at 2,000 arxr for 30 
minutes at 4°C. The clear supernates were decanted, the tubes drained for 30 minutes, and 
the inside surface of the tubes above the precipitates swabbed to dryness. The tubes were each 
counted in the well-type scintillation counter and the number of counts expressed as a  per- 
centage of the total counts added. All samples were tested in duplicate and agreement within 
5 per cent of the average was required. The per cent I*WSF bound by serial dilutions of a 
given serum was plotted on semilog paper. The anti-WSF titers expressed as binding units were 
calculated from this data (see Results). 
Immunologic Reactivity  of the Rabbit  Anti-WSF.--The specificity of the interaction between 
the rabbit anti-WSF and I*WSF  (I*WSF-anti-WSF system) was shown by the capacity of 
whole rabbit spinal cord to adsorb anti-WSF and by the capacity of unlabeled WSF to inhibit 
the I*WSF-anti-WSF system. Three gm of rabbit spinal cord, kidney, and liver were indi- 
vidually homogenized in 12 ml of borate buffer and centrifuged at 2,500 ar~s for 30 minutes at 
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FIG. 1.  Paper electrophoretic analysis of the ItaX-labeled WSF 
4°C. The homogenates were washed three times, serially diluted in 2 ml borate buffer, and 
mixed with equal volumes of a 1 : 10 dilution of an anti-WSF serum of known titer. These mix- 
tures of tissue homogenate and serum were incubated with frequent shaking for 24 hours at 
4°C and then centrifuged at 14,000 arm for 30 minutes. The capacity of the superuates to bind 
the I*WSF was measured as previously described and compared to the per cent I*WSF bound 
by a  1:20 dilution of the unadsorbed anti-WSF serum. In the inhibition studies, unlabeled 
WSF, bovine serum albumin, and human serum globulin were added separately to the I*WSF 
solution in concentrations ranging from 1 to 100 gamma/0.5 ml and these mixtures used in the 
I*WSF-anti-WSF system with an anti-WSF serum of known titer. 
Complement fixation (13), a modified quantitative precipitin (P-80) (14), and Ouchterlony 
tests (15)  were carried out with the unlabeled WSF and randomly selected sera, including 
several with high 40 per cent saturated ammonium sulfate titers of anti-WSF antibodies. The 
immunofluorescent technique was used in an attempt to show a  specific interaction between 
anti-WSF serum and whole nervous tissue. Thin, frozen sections of normal rabbit cord were 
exposed to fluorescein isothiocyanate-labeled globulin from a  high titered anti-WSF serum, 
washed with normal rabbit serum, and observed with an ultraviolet microscope. 
RESULTS 
Chemical Characterization  of the Rabbit Cord  WSF.--Fig.  I  shows  a  typical 
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after paper electrophoresis  in veronal buffer  at pH 8.6. Although this figure 
illustrates the pattern of the I*WSF, it is equally representative of the un- 
labeled WSF. Practically all of the protein-stained material moved toward the 
cathode as a  broad, double peaked band. Since the nitrogen content of the 
WSF was 16 per cent, it would appear that the WSF consists almost entirely 
of a mixture of electrophoretically  similar, basic proteins. 
Chemical Ckaracterization and Biological Activity of the I*WSF.-:-As indicated 
above the brom-phenol blue-stained patterns of the unlabeled WSF and I*WSF 
were similar.  The ninhydrin-stained patterns of the two materials were also 
similar by visual comparison and it would appear,  therefore, that the iodination 
procedure  did not cause any significant denaturation of the proteins.  As shown 
in Fig.  1 the distribution of radioactive counts on the I*WSF corresponded 
roughly to the intensity of the brom-phenol blue stain. It is apparent that the 
slower moving components  were proportionately more heavily iodinated than 
the rapidly moving elements. 
The addition of 10 per cent TCA to the I*WSF precipitated 55 per cent of the 
total radioactive counts.  Although dialysis of the I*WSF for an additional 3 to 
4 days increased the percent precipitated by 10 per cent TCA, repassage of the 
I*WSF through the amberlite resin column did not. The per cent of the total 
I*WSF counts precipitated by 10 per cent TCA fell gradually to 40 per cent 
by the 5th week. Again this per cent was not increased by passage of the I*WSF 
through the ion exchange column. These facts suggest that a major proportion 
of  the  I*WSF  solution consists  of polypeptides or  small  molecular  weight 
proteins and that the proportion of these constituents is increased with time. 
Two of the three rabbits injected with I*WSF of low specific activity dis- 
played paralysis 12 and 20 days, respectively,  after injection.  Thus iodination 
of  the  WSF  did not alter its  encephalitogenic  activity when injected into 
rabbits. 
Induction  of EAE in Rabbits Injected with the Rabbit Cord WSF.-- 
The forty-nine rabbits injected with the WSF-adjuvant emulsion were divided into five 
experimental groups: group I  consisted of fourteen rabbits that received 0.5 nag of WSF per 
rabbit; group II, thirteen rabbits, 2.0 mg each; group III, nine rabbits, 5.0 mg each; group IV, 
nine rabbits, 8.0 mg each; and group V, four rabbits, 12.0 mg each. All groups received 1.6 mg 
of mycobacteria per rabbit. 
Almost without exception  the first sign of EAE was the dragging of one or 
both hind legs or failure of the rabbit to bring the legs securely up under his 
haunches. Failure to eat and weight loss frequently accompanied  or preceded 
these findings. Rabbits that became sick before the end of the 3rd week fre- 
quently progressed  to complete  paralysis of two or more extremities over a 
24 to 48 hour period.  In others,  particularly those that developed EAE after 812  ANTIBODY  STUDIES  IN  RABBIT  ENCEPItALOMYELITIS 
TABLE  I 
Results  in the Five Experimental  Groups of Rabbits  Injected  with WSF 
Group  Rabbit  No 
I  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
II  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
III  1 
2 
3 
4 
5 
6 
7 
8 
9 
Weight  Onset EAE  Rabbit  killed 
kg  day 
2.4 
2.6 
2.7 
2.6 
2.2 
2.4 
2.7 
2.1  18 
2.1  18 
2.4  25 
2.0  27 
2.3  31 
2.0  33 
2.6  45 
2.8 
2.2 
2.4 
2.6 
2.7 
2.5  15 
2.4  18 
3.0  18 
2.4  18 
2.2  18 
3.0  18 
2.7  22 
2.3  25 
2.4  m 
2.5 
2.3 
2.3 
2.6  18 
2.3  18 
2.7  20 
2.5  25 
2.4  26 
Clinical 
illness 
day 
60  None 
60 
60 
60  " 
60  ~c 
60  " 
60 
18  4+ 
20  4--I-- 
28  4+ 
28  4+ 
32  4+ 
44  2+ 
50  2+ 
60  None 
60  " 
60  . 
60 
60  cc 
16  4+ 
20  4+ 
18  4+ 
18  4+ 
18  4+ 
18  4+ 
24  4+ 
28  4+ 
60  None 
60 
60  cc 
60  ~c 
18  4+ 
18  4+ 
20  4+ 
32  3+ 
32  3+ 
Histologi 
changes 
N.E.* 
~c 
cc 
3+ 
2+ 
1+ 
2+ 
2+ 
1+ 
2+ 
N.E. 
~c 
cc 
4+ 
2+ 
3+ 
2+ 
4+ 
4+ 
2+ 
2+ 
N.E. 
c¢ 
c~ 
¢¢ 
4+ 
3+ 
3+ 
2+ 
2+ 
Binding units 
Day of death 
0 
0 
0 
0 
13 
81 
160 
0 
0 
0 
0 
0 
0 
0 
0 
10 
10 
44 
96 
0 
80 
0 
0 
80 
320 
0 
0 
0 
40 
35 
60 
0 
21 
0 
0 
0 
* N.E, not examined. ROBERT  F. EIBLER AND  ARTHUR  E. BARNES 
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Group  Rabbit  No.  Weight 
kg 
2.2 
2.1 
2.1 
2.8 
2.5 
2.7 
2.6 
2.3 
2.2 
2.7 
2.0 
2.6 
2.3 
Onset EAE  Rabbit killec 
day  day 
--  60 
--  60 
15  16 
16  18 
22  24 
25  28 
25  32 
28  32 
48  50 
--  60 
--  60 
14  14 
18  18 
Clinical 
illness 
None 
c¢ 
4+ 
4+ 
4-{- 
4+ 
2-{- 
3-{- 
4-{- 
None 
~c 
4+ 
4+ 
Histologic 
changes 
cc 
~c 
¢¢ 
¢c 
l+ 
4+ 
N.E. 
g~ 
4+ 
3+ 
Binding unitl 
Day of  deatt 
0 
36 
28 
110 
320 
35 
100 
22 
27O 
0 
35 
15 
90 
the 3rd week, paresis was more gradual in onset and in some became stabilized 
at a point of mild to moderate hind leg weakness. The degree of clinical disease 
in each rabbit, graded solely on the basis of the rapidity of development and 
extent of the paralysis, is given in Table I. 
The incidence and rate of onset of EAE in experimental groups  I  to IV, 
expressed in  terms of cumulative per cent rabbits sick at successive 10 day 
intervals after injection, are plotted in Fig. 2 from the data presented in Table I. 
Group V  was excluded from the chart because of the inadequate size of this 
group. All groups showed a  progressive increase in the total per cent of sick 
rabbits through the 30th day. A  slight, but probably insignificant, difference 
in the per cent of rabbits sick among the four groups was apparent at the end 
of 2  months.  However, for the first 30 days after injection, group I  dearly 
lags behind the other groups. The average day of onset of EAE in these four 
groups was 28,  19, 21, and 26, respectively. Rabbit 9, group IV, seems excep- 
tional in view of the development of maximum degree of clinical illness and 
histologic change with an onset of disease which is later than for any of the 
other sick rabbits.  Exclusion of this rabbit from group IV in calculating the 
average day of onset of EAE makes the group IV average 22 days rather than 
26 days. Since the day of onset of EKE is considered an important quantitative 
parameter of the disease  (16), it would appear  then that  there was  a  dose- 
response relationship up through the 2 mg dose of WSF. The lack of a signifi- 
cant difference in the incidence and rate of onset of EAE among  the  three 
groups of rabbits receiving 2 or more milligrams of WSF may indicate that the 
dose range at which the encephalitogenic response is no longer proportional to 
dose had been reached. Weight differences among the rabbits at the time of 814  ANTIBODY  STUDIES  IN  RABBIT  ENCEPHALOMYELITIS 
injection  (Table I)  did  not  seem to have any influence  on  the  incidence  or 
severity of the disease among the animals of a single group or of the  different 
groups. The twelve control rabbits which received Freund's complete adjuvant 
without WSF were observed for 3 months and did not develop signs of paresis 
or paralysis. 
Histological examination of the brain and spinal cord of animals with EAE 
showed meningeal,  subpial,  and perivascular collections of mononuclear cells 
and  pleomorphic  macrophages.  Myelin  stains  showed  accompanying  loss  of 
100 1  WS F~mRgObbit  Group  No. 
Rabbits 
13  2.0 
9  5.0 
70  8.0 
UJ  60 
5o 
II  --  20  21--  30  31--  40 
m 
41--  50 
DAYS  AFTER  INJECTION 
m 
51--60 
Fla. 2.  The cumulative per cent of animals that developed EAE 
myelin  in  those  areas  infiltrated  with  macrophages.  Where  these  changes 
extended into the gray matter of the cord, neurons were well preserved in most 
instances.  Although  the spinal cord was predominantly affected, lesions were 
also observed in some animals in  the deep white matter of the cerebral and 
cerebellar hemispheres and in the optic nerves and tracts. In Table I the changes 
observed in each rabbit with EAE are graded on the basis of their extent and 
severity, although some difficulty in grading was occasioned by a  discrepancy 
in  these parameters in  certain animals.  For example, many or most sections 
of a  cord  from a  rabbit with  EAE  might  show  minimal  changes  while  one 
section might show severe involvement. In addition,  selected  portions  only, 
and not the entire cord or brain, were sampled. 
P~,r cent I*WSF  Bound  by  Serum from Adjuvant-Injected-  and  WSF-In- 
jected  Rabbits.--Table  II shows  the per cent  I*WSF bound by sera from the ROBERT  F.  KIBLER AND  ARTHUR E. BARNES  815 
twelve control rabbits before and after injection of Freund's complete adjuvant. 
The per cent I*WSF bound by the serum from each rabbit prior to  injection is 
the average of three sera obtained at weekly intervals prior to injection.  The 
preinjection values of the twelve control rabbits ranged between 2.1  and 6.6 
per cent. While eleven of the twelve rabbits fell within a  more narrow range 
(2.1  to 3.4 per cent),  the high value of 6.6%  for rabbit  10  shows  that wide 
variation  may  occur.  Similar  variation  among  preinjection  sera  has  been 
observed in other groups of animals.  It is clear  from inspection of the prein- 
TABLE  II 
Par Cent I*WSF Bound by 1:10 Dilutions of Adjuvant Control Rabbit Sara 
Rabbit 
No. 
1  2.9  2.5  2.5 
2  2.4  4.0  3.8 
3  2.6  2.4  3.4 
4  2.2  2.2  1.9 
5  2.4  2.5  3.5 
6  2.5  2.4  2.4 
7  3.0  2.6  3.4 
8  2.1  2.7  3.2 
9  2.8  3.2  2.6 
10  6.5  6.4  6.8 
11  2.6  3.1  2.7 
12  3.0  2.5  2.6 
Mean. 
SD. 
Days  preinjection  Days posfinjection 
10  14  7  4  0  Average 
2.6 
3.4 
2.8 
2.1 
2.8 
2.4 
3.0 
2.7 
2.9 
6.6 
2.8 
2.7 
+0.2* 
+0.3 
+1.0 
+0.5 
+1.0 
+0.9 
+1.5 
+1.1 
+1.6 
+0.5 
+0.2 
+0.4 
+O.8 
~0.5 
+0.9 
+1.2 
+1.6 
+1.0 
-0.2 
+1.4 
+1.4 
+1.1 
+1.2 
+0.2 
+0.3 
+0.3 
+0.9 
4-0.6 
22  28  36 
+1.5  +1.2  +2.0 
+0.4  +0.4  +2.4 
+1.2  +1.2  +3.2 
+1.4  +1.0  +1.7 
+0.9  +1.1  +2.5 
+2.0  +1.9  +1.8 
+1.1  +1.3  +1.6 
+0.6  +1.1  +2.3 
+1.1  +1.0  +1.9 
+0.3  +0.4  +0.4 
+1.0  +I .3  +1.3 
+0.1  -0.2  0.0 
+1.0  +1.0  +1.8 
"4-0.6  "4-0.5  -4-0.8 
44  50 
+2.7  +1.5 
+3.1  +2.9 
+3.6  +3.8 
+2.2  +1.9 
+2.9  +2.3 
+1.9  +1.8 
+2.0  +2.6 
+3.3  +3.3 
+2.8  +2.3 
+1.4  +1.7 
+1.4  +1.4 
--0.3  --0.4 
+2.2  +2.3 
:kl.0  4-1.1 
* Difference between preinjection and postinjection per cent I*WSF bound. 
jection data in Table II that such variationswere not the result of experimental 
error,  but were a  consistent quality of the serum from an individual rabbit. 
It is apparent,  therefore,  that each rabbit's own preinjection serum must be 
used  as  a  control  for subsequent  observations rather  than  the  mean  of  the 
control  group. 
Following  injection  of  Freund's  complete  adjuvant  eleven  of  the  twelve 
showed a  gradually progressive increase in per cent  I*WSF bound above the 
preinjection value. In Table II the per cent I*WSF bound after injection has 
been expressed for each rabbit as the difference between the per cent I*WSF 
bound on the postinjection day observed and the average preinjection value. 
The average of these differences for the group as a  whole  is recorded for each 
postinjection day at the bottom of each column. From the  10th through the 816  ANTIBODY  STUDIES IN RABBIT ENCEPHALOMYELITIS 
50th day there is a gradual rise in these differences from +0.8 ±  0.5 per cent 
to +2.1  ±  1.1 per cent. 
The reason for the variation in solubility of the I*WSF in individual, control 
rabbit sera and the reason for the slight increase in the per cent I*WSF pre- 
cipitated in the presence of sera from rabbits injected with Freund's complete 
adjuvant are not entirely clear. However, preliminary studies suggest that these 
features may be correlated in a non-specific manner with the amount of globu- 
lin present in the sera.  For example, a  slight but definite increase  in fl and 
"r-globulin was observed in the serum electrophoretic patterns of those rabbits 
which received Freund's complete adjuvant only (17). 
It can now be appreciated that the per cent I*WSF bound by the serum from 
a rabbit injected with WSF is influenced by factors other than the absence or 
presence of anti-WSF. These factors are:  (a)  the solubility of the I*WSF in 
control rabbit serum as reflected by the per cent I*WSF bound by the rabbit's 
own preinjection serum,  (b)  the  effect of the adjuvant  on  this  solubility as 
estimated from the mean increase in per cent I*WSF bound by the adjuvant 
control group at  the same  time period after injection, and  (c)  experimental 
variation. The influence of the first two factors was determined from the experi- 
mental data and allowance for experimental error was made by the addition 
of four standard deviations to the mean of the adjuvant control group. These 
factors were made the basis of an arbitrarily defined "lowest significant level" 
of I*WSF  bound.  Below  this  level  the  three factors listed were  considered 
important influences and above this level binding was considered due to the 
presence of anti-WSF.  For  example,  given a  serum  obtained  22  days  after 
injection which bound 10 per cent I*WSF, a preinjection serum from the same 
rabbit which bound 4.0 per cent, and an average increase in per cent I*WSF 
bound by the adjuvant control group on the 22nd day after injection of 1.0 
±  0.6 per cent; the lowest significant level of binding by this serum would be 
4.0 per cent  (preinjection serum)  plus 1.0 per cent (adjuvant  control group) 
plus 4 X  0.6 per cent (four standard deviations) or 7.4 per cent. The per cent 
I*WSF bound related to the presence of anti-WSF would then be 10 per cent 
minus 7.4 per cent which equals 2.6 per cent. 
So that  the  anti-WSF  content of different sera could be more accurately 
compared, the amount of anti-WSF in each 0.5 ml of serum was expressed in 
arbitrary  terms  of  a  "binding  unit."  The binding  unit  was  defined as  the 
reciprocal of the serum dilution at which the per cent I*WSF bound fell below 
the lowest significant level as defined above. Fig. 3 shows how these quantita- 
tive values were calculated in the case of rabbit 9, group IV. Serum dilutions 
are expressed along the ordinate of the semilog paper. The total per cent I*WSF 
bound  by each  serum  dilution minus  the lowest significant level of I*WSF 
bound is scaled along the abscissa. Accordingly, the reciprocal of the dilution 
at  which  the  anti-WSF  serum  dilution  curve crosses  the  base  line becomes ROBERT  1;'. KIBLER  AND  ARTHUR  E.  BARNES  817 
the binding unit per 0.5 mi of the undiluted serum. This method for determi- 
nation of anti-WSF binding units disregards the fact that 1:10 pooled normal 
rabbit serum was used as the diluent at antiserum dilutions above 1:10. It is 
apparent  that  with  progressive dilution of the  anti-WSF  serum,  the  lowest 
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antibody dilution curves with the base line represent binding units. 
significant level of binding would be determined more and more by the non- 
specific binding properties of 1:10 normal rabbit serum diluent and less and 
less by the non-specific binding properties of the anti-WSF serum. However, 
since the per cent I*WSF bound by pooled normal rabbit serum never exceeded 
4.0 per cent, the use of a lowest significant level of binding based on the calcu- 
lations  described  above  for  all  serum  dilutions  tended  to  provide  a  larger 
rather than a smaller margin for significance. 
The results obtained in the five groups of rabbits injected with the water- 818  ANTIBODY  STUDIES IN RABBIT ENCEPHALOI/YELITIS 
TABLE  HI 
Serial Anti-WSF Tigers of tlm Five Groups of WSF-Injeaed Rabbits 
Binding units 
Rabbit  Days after injection 
Group  No. 
14  16  18  20  24  28  32  38 
H 
III 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
0 
0 
0 
0 
0 
o  (o) 
0 
0 
0 
0 
51 
0 
0 
0 
10 
0 
0 
0 
0 
0 
0 
0 
(o)* 
(8o) 
(o) 
(o) 
(320) 
(o) 
(21) 
(o) 
0 
0 
0 
0 
0 
(80) 
0 
15 
10 
0 
(o) 
0 
0 
0 
0 
0 
0 
0 
40 
12 
0 
0 
0 
13 
15 
(o) 
0 
0  0 
17 
12  14 
0 
O) 
(o) 
(o) 
o  o  (o) 
o  (o) 
0  0 
0  0 
0  0 
0  0 
0  12 
40  60 
15  70 
(o) 
0  0 
0  0 
0  0 
0  0 
0 
10  12 
22  40 
0  0 
20 
30 
60 
44  50 
0  0 
0 
0 
0 
0  13 
81 
160 
(o) 
o  (o~ 
0 
10 
10 
44 
96 
0 
40 
35 
6O 
* Parentheses indicate day rabbits with EAE were sacrificed. ROBERT ~.  KIBLER AND ARTHUR E.  BARNES 
TABLE IH--Concluded 
819 
Binding units 
Rabbi :  Days after injection 
Group  No 
14  16  18  28 
Iv 
v 
0 
0 
18 
0 
14 
0 
0 
0 
0 
0 
0 
(15) 
9o 
(28) 
40  (110) 
0 
(9O) 
20  24 
0  15 
10  20 
52  (320) 
11  19 
38  84 
0  13 
15  20 
0 
0 
(35) 
(iOO) 
22 
29 
0 
20 
32 
15 
38 
(22) 
60 
38 
2OO 
0 
S1 
44  50 
0  0 
38  36 
(2701 
0 
35 
soluble fraction can now be considered. Table I  gives the antibody titers of 
these rabbits at the time of sacrifice. Out of the total of twenty-nine rabbits 
which developed EAE, thirteen had circulating anti-WSF and sixteen did not; 
while of the twenty animals which survived, twelve demonstrated circulating 
anti-WSF and eight did not. Inspection of Table III, which records the serial 
antibody  titers  in  each  animal,  reveals  additional  information.  Circulating 
antibodies did not make their appearance in any of the animals prior to the 14th 
day after injection. However, from the 14th day through the 20th day, fifteen 
animals developed significant antibody titers and twelve of these were rabbits 
which had, or subsequently developed, EAE. The initial appearance of circu- 
lating antibody, when it occurred after the 3rd week, was observed exclusively 
in the surviving animals with the exception of rabbit 8, group IV. This rela- 
tionship between early appearance of antibody and EAE is illustrated in Fig. 4 
in which the titers of all rabbits which made anti-WSF are charted. It is also 
clear  that,  as  a  group,  the  antibody-producing animals  which  survived had 
lower titers than the antibody-producing animals with EAE, and of the three 
surviving rabbits which made antibody before the end of the 3rd week, none 
had  over  10 binding  units/0.5  ml  undiluted  serum.  Rabbit  9,  group  IV,  is 
again of special interest in view of the very high antibody titer and late onset 
of disease. 
Specificity of the Rabbit Anti-WSF.--The results of the tissue adsorption 
studies in which an anti-WSF serum was  exposed to homogenates of rabbit 
spinal  cord, kidney, and liver are shown in Table IV. The anti-WSF serum 820  ANTIBODY STUDIES  IN  RABBIT  ENCEPHALOMYELITIS 
bound 16 per cent of the I*WSF both before and after exposure to liver and 
kidney homogenates, but after adsorption by the rabbit spinal cord homogenate 
the anti-WSF bound only 8 per cent.  These results indicate that at least S0 
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FIG. 4.  Anti-WSF titers of sera from all animals with detectable circulating  antibodies 
The solid lines and circles  represent the animals with EAE, and the broken lines and open 
circles the animals that survived. 
per cent of the binding capacity of the anti-WSF serum was specific for rabbit 
spinal cord. 
The inhibition of the binding capacity of an anti-WSF serum by unlabeled ROBERT  F.  KIBLER  AND  ARTHUR  E.  BARNES  821 
WSF is shown in Table V. Significant inhibition was achieved with 0.1 gamma 
unlabeled WSF/0.5 ml of the  I*WSF test solution and complete inhibition of 
the binding capacity of the anti-WSF serum tested was achieved with a con- 
centration of  10 gamma/0.5 ml. Neither bovine  serum albumin nor human 
gamma globulin showed any effect over the same range of protein concentra- 
tion. 
Complement fixation,  quantitative precipitin,  and Ouchterlony tests failed 
to detect antibody to the water-soluble fraction in any of the sera tested, in- 
cluding those with high 40 per cent SAS anti-WSF titers. Attempts to show a 
specific interaction between an anti-WSF serum and frozen tissue sections  of 
Table IV 
Tissue Sp~if~ity of the A~i-WSF 
Tissue  dilution 
1:1 
1:2 
1:4 
1:8 
1:32 
Spinal cord 
s~ 
8 
9 
9 
10 
Tissue used to adsorb test antiserum* 
Liver 
15 
15 
Kidney 
16 
15 
* A 1:20 dilution of the unadsorbed test antiserum bound 16 per cent and a  1:20 dilution 
of pooled normal rabbit serum bound 4 per cent. 
Per cent I*WSF bound. 
normal rabbit cord by the fluorescein technique were unsuccessful because of 
the marked non-specific staining obtained with control  sera.  This was pre- 
sumably due to the high degree of affinity between  fluorescein and fatty sub- 
stances of the cord such as myelin. 
DISCUSSION 
Induction  of  experimental  allergic  encephalomyelitis  (EAE)  with  water- 
soluble  protein fractions of nervous  tissue  has been  previously reported  in 
guinea pigs  (8). It is of interest, therefore,  that one of these fractions is also 
effective in inducing EAE in rabbits, even when extracts of homologous nervous 
tissue  are employed.  The qualitative features of the clinical and histological 
changes  appeared  identical to  those observed  previously  in  this  laboratory 
(17), and by Morrison (18), in rabbits injected with whole rabbit cord. The 
quantitative features of the disease also compare favorably with those reported 
by Waksman and Morrison (19) in whole cord-injected rabbits, with the ex- 
ception that the average day of onset of EAE in the latter study was 13 days 
compared to 22 days (groups II to V) in the present report. However,  this lag 822  ANTIBODY  STUDIES IN RABBIT ENCEPHALOMYELITIS 
in time of onset might be related not only to differences in effectiveness of the 
two encephalitogenic  agents but also to differences  in the adjuvant mixtures 
used in  the  two studies  since  certain  features  of  the adjuvant,  such  as  its 
viscosity and the ratio of mycobacteria to antigen, are now known to modify 
the quantitative parameters of the disease (20-22). 
Although  complete chemical  analysis of the WSF was not carried out,  it 
seems  reasonable  to  assume  that  the  water-soluble fraction  of rabbit  cord 
prepared for these studies is principally protein since it contained 16 per cent 
nitrogen by weight and, as shown by Roboz and Henderson in their prepara- 
tions from bovine cord, only small amounts of carbohydrates and lipids.  The 
high degree of biological activity demonstrated for certain of these preparations 
TABLE  V 
The Blocking Effect of Unlabeled WSF on the In vitro Binding of AntI-WSF 
Concentration of unlabeled WSF  I*WSF bound by a 1:10 dilution of an  anti-WSF serum* 
Gamma~0.5 ml I*WSF 
0 
0.05 
0.1 
1.0 
10.0 
100.0 
l~er tent 
23 
22 
18 
13 
7 
6 
* Lowest significant level of binding for this serum was 7 per cent. 
in guinea pigs by Kies and Alvord (8) suggests that the encephalitogenlc  agent 
in such preparations is itself protein in nature. The latter workers showed that 
a citrate extract of partially defatted bovine cord had 30 per cent of the activity 
of lyophilized whole cord. Although no such comparison has been attempted in 
this study, it has been recently found that 50 gamma WSF/rabbit is an effective 
encephalitogenic  dose,  EKE having been induced in a/~ injected rabbits with 
an average day of onset of 27 days. Thus if the encephalitogenlc  agent is not 
protein, it must be some extremely potent lipid or polysaccharide contaminant. 
The ammonium sulfate precipitation method of Farr (9) depends upon the 
precipitation  of I* antigen-antibody complexes  under  conditions selected so 
that any of the uncomplexed I* antigen remains in solution. This test has been 
used extensively in the BSA-anti-BSA system and a concentration of 50 per 
cent saturated ammonium sulfate (SAS) has been employed. A concentration 
of 40 per cent SAS was used in the present study, however, since the I*WSF 
was considerably more soluble at this concentration. 
Despite the fact that some rabbits developed EAE without detectable circu- 
lating anti-WSF and others had anti-WSF  without EKE,  the occurrence  of ROBERT  F.  KIBLER  AND  ARTHUR  E.  BARNES  823 
EAE in twelve out of the fifteen rabbits which had antioWSF before the end 
of the 3rd week suggests a possible relationship between antibody and disease. 
The difference in the height of the anti-WSF fiters between the rabbits with 
EAE and those which survived is also suggestive. The occurrence of EKE in 
some rabbits without measurable anti-WSF may, as proposed by Kabat (23), 
be due to rapid clearing of antibody from the circulation by central nervous 
system tissue although the binding of anti-brain antibody in vivo has yet to be 
shown.  Nevertheless,  strong  evidence  for  nervous  tissue  specificity  of  the 
anti-WSF is shown by adsorption of the anti-WSF with fresh rabbit cord but 
not with kidney or liver tissue homogenates. While the high anti-WSF titers 
in some of the rabbits with EAE may be eventually attributed to concomitant 
rather than primary immunologic processes, further investigation of the role 
of antibody seems warranted, especially so, as more purified encephalitogenic 
preparations become available. 
SUMMARY 
A water-soluble protein fraction of nervous tissue was prepared by extraction 
of rabbit spinal cord with sodium citrate at pH 4.3. Characterization by nitro- 
gen  content  and  paper  electrophoresis showed  it  to  be  a  mixture  of basic 
proteins. This extract demonstrated encephalitogenic activity when injected 
into rabbits. 
The most suitable technique for the measurement of serum antibody to the 
rabbit cord antigen proved to be the precipitation of antigen-antibody com- 
plexes by 40 per  cent saturated  ammonium  sulfate.  Antibody could not be 
demonstrated by the techniques of complement fixation, quantitative precipi- 
tation, and Ouchterlony plates. 
The early appearance of circulating antibody occurred almost exclusively in 
rabbits  that  subsequently developed EAE.  Specificity of  the  antibodies  for 
nervous  tissue  was  demonstrated  by  appropriate  blocking  and  adsorption 
experiments. 
We wish to thank Mrs. Nancy Dohner for her technical assistance, Dr. David Porter for 
having performed the complement  fixation tests, and Dr. Richard Farr for his helpful advice 
and criticism. 
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